Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-27

Clinical Trial Update: Cytisine for Smoking Cessation [Phase 4]

View source ↗

Summary

Phase 4 trial of cytisine for smoking cessation has completed. The study focused on tobacco use disorder and comorbid alcohol use disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cytisine (cytisine)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Tobacco Use Disorder, Alcohol Use Disorder | Phase 4 | Status: COMPLETED